发明名称 COMPOUNDS
摘要 A compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof: wherein X is an oxygen or sulphur atom A is CH(R<SUP>6</SUP>)-, -O- or NR<SUP>7</SUP> or when A is NR<SUP>7</SUP>, then R<SUP>1</SUP> and NR<SUP>7</SUP> can together form a ring such that R<SUP>1</SUP> and R<SUP>7</SUP> are (CH<SUB>2</SUB>)<SUB>n</SUB>, where n is 2-4, preferably 2-3; Y is a bond, CH(R<SUP>6</SUP>)-, -O- or NR<SUP>7</SUP> or A and Y together form a single bond between the aromatic group and the carbonyl group but when A is-O- then Y is not -O-; R<SUP>1</SUP> and R<SUP>2</SUP> are independently hydrogen, halogen, OR<SUP>8</SUP>, NR<SUP>9</SUP>R<SUP>10</SUP>, NR<SUP>9</SUP>COR<SUP>11</SUP>, NR<SUP>9</SUP>SO<SUB>2</SUB>R<SUP>11 </SUP>or C<SUB>1-6</SUB> alkyl optionally substituted by fluorine, hydroxyl, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>3</SUP> is C<SUB>1-6</SUB> alkyl, C<SUB>3-8</SUB> cycloalkyl C<SUB>4-10</SUB> alkylcycloalkyl optionally substituted by hydroxyl, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>4</SUP> is hydrogen, halogen, CF<SUB>3</SUB>, OR<SUP>9</SUP>, NR<SUP>9</SUP>R<SUP>10</SUP>, NR<SUP>9</SUP>COR<SUP>11</SUP>, NR<SUP>9</SUP>SO<SUB>2</SUB>R<SUP>11</SUP> or C<SUB>1-6</SUB> alkyl optionally substituted by hydroxyl, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>5</SUP> is hydrogen, halogen, CF<SUB>3</SUB>, OR<SUP>8</SUP>, COOR<SUP>9</SUP>, CONR<SUP>9</SUP>R<SUP>10</SUP> or SO<SUB>2</SUB>R<SUP>11</SUP>; R<SUP>6</SUP> is hydrogen, C<SUB>1-6</SUB> alkyl, C<SUB>3-8</SUB> cycloalkyl C<SUB>4-10</SUB> alkylcycloalkyl, C<SUB>1-6</SUB> alkyl optionally substituted by hydroxyl, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>7 </SUP> is hydrogen, C<SUB>1-6</SUB> alkyl optionally substituted by C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>, phenyl wherein said phenyl group is optionally substituted by one or more substituents selected from halogen, C<SUB>1-6</SUB> alkyl, CF<SUB>3</SUB>, OCF<SUB>3</SUB> or OR<SUP>9</SUP>; R<SUP>8</SUP> is hydrogen or C<SUB>1-6</SUB> alkyl optionally substituted by fluorine, C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>9</SUP> is hydrogen, C<SUB>1-6</SUB> alkyl or C<SUB>1-3</SUB> alkylphenyl wherein said phenyl group is optionally substituted by one or more substituents selected from halogen, C<SUB>1-6</SUB> alkyl optionally substituted by fluorine, OR<SUP>8</SUP>, NR<SUP>9</SUP>R<SUP>10</SUP>; R<SUP>10</SUP> is hydrogen, C<SUB>1-6</SUB> alkyl, C<SUB>3-8</SUB> cycloalkyl C<SUB>4-10</SUB> alkylcycloalkyl, C<SUB>1-6</SUB> alkenyl, phenyl or C<SUB>1-3</SUB> alkylphenyl wherein said phenyl groups are optionally substituted by one or more substituents selected from halogen, C<SUB>1-6</SUB> alkyl optionally substituted by fluorine, OR<SUP>8</SUP>; or the groups R<SUP>9</SUP> and R<SUP>10</SUP> when they are attached to a nitrogen atom may together form a 5- or 6-membered ring which optionally contains one further heteroatom selected from NR9, S and O; and R<SUP>11</SUP> is C<SUB>1-6 </SUB>alkyl or a phenyl group optionally substituted by one or more substituents selected from halogen, C<SUB>1-6</SUB> alkyl, CF<SUB>3</SUB>, OCF<SUB>3</SUB> or OR<SUP>8</SUP>; with the provisos that when A is -O- or NR<SUP>7</SUP> and Y is CH(R<SUP>6</SUP>) then R<SUP>6</SUP> is not C<SUB>1-6</SUB> alkoxy or NR<SUP>9</SUP>R<SUP>10</SUP>; when
申请公布号 WO2008107677(A2) 申请公布日期 2008.09.12
申请号 WO2008GB00761 申请日期 2008.03.06
申请人 SENEXIS LIMITED;SCOPES, DAVID, IAN, CARTER;CHEESERIGHT, TIMOTHY, JOHN;VINTER, JEREMY, GILBERT 发明人 SCOPES, DAVID, IAN, CARTER;CHEESERIGHT, TIMOTHY, JOHN;VINTER, JEREMY, GILBERT
分类号 主分类号
代理机构 代理人
主权项
地址